Ep.42- The Dangers of Ozempic, Wegovy, and other GLP-1 Agonists (Semaglutide)

The Metabolic Edge Podcast

Follow this link to apply for the fall/winter intake of the 12-week immersion program https://andrewappletonmd.ca/cmbh/

In this episode, Tommy and Andrew discuss the rise in popularity of weight loss drugs (like Ozempic) including potential benefits, significant harms, and unknown long-term side effect profiles of the boomin drug class.

To listen to explicit episodes, sign in.

Stay up to date with this show

Sign in or sign up to follow shows, save episodes and get the latest updates.

Select a country or region

Africa, Middle East, and India

Asia Pacific

Europe

Latin America and the Caribbean

The United States and Canada